Herrera-Uribe Juber, Stevenson Nigel J
Viral Immunology Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Eur J Immunol. 2025 Aug;55(8):e51645. doi: 10.1002/eji.202451645.
Suppressor of cytokine signaling (SOCS) proteins are crucial components of the immune response against viral infections. SOCS proteins inhibit cytokine signaling through various mechanisms, such as blocking STAT binding to JAKs and targeting proteins for ubiquitination and degradation. While these proteins maintain immune balance by suppressing excessive inflammatory responses, many viruses, including SARS-CoV-2, exploit SOCS proteins to evade host immunity. In consequence, understanding their modulatory functions in viral disease has become increasingly relevant. Therefore, this review aims to describe and discuss studies involving SOCS expression data in COVID-19 and their potential modulation as a valuable use for therapeutic strategies.
细胞因子信号转导抑制因子(SOCS)蛋白是抗病毒感染免疫反应的关键组成部分。SOCS蛋白通过多种机制抑制细胞因子信号转导,如阻止信号转导和转录激活因子(STAT)与Janus激酶(JAK)结合以及靶向蛋白质进行泛素化和降解。虽然这些蛋白通过抑制过度的炎症反应来维持免疫平衡,但包括严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在内的许多病毒利用SOCS蛋白来逃避宿主免疫。因此,了解它们在病毒性疾病中的调节功能变得越来越重要。因此,本综述旨在描述和讨论涉及2019冠状病毒病(COVID-19)中SOCS表达数据的研究及其作为治疗策略的潜在调节作用。